Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered leaving before President-elect Donald Trump’s first term in office, said one former and one current official.

Food and Drug Administration commissioner Robert Califf said he was “disappointed” with the presidential election result and is uncertain about the agency’s future under Donald Trump. “I’m biased, but I feel like the FDA is at peak performance right now and we’ll just see what happens as the new team comes in,

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s hostility to civil servants, Califf said. Trump has said he plans to give Kennedy, leader of the “Make America Healthy Again” movement, power over health care policy in his administration.